THC Q2 adj EPS $6.12 vs. est. $4.26 and Q2 revs $5.63B vs. est. $5.44B; now sees FY26 adjusted EPS $20.30-$21.69 above consensus $17.85 and

THC Q2 adj EPS $6.12 vs. est. $4.26 and Q2 revs $5.63B vs. est. $5.44B; now sees FY26 adjusted EPS $20.30-$21.69 above consensus $17.85 and year revs $21.9B-$22.5B, vs. consensus $21.98B; authorizes $2B increase to share repurchase program; shares +15% premarket in hospital sector